Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 08/01/23 07:00:00 on US and Canada Markets.
Agreement provides ProQR with initial payment of €12.5M and up to €135M in further payments, as well as potential additional earn outs based on commercial sales in the US and EU Divestment of sepofarsen and ultevursen supports ProQR’s strategic focus on the Axiomer&...
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023, at 3:00 p.m. ET. An audio webcast of the presentation will be available...
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that management will host a conference call and live audio webcast on August 8, 2023 at 8:30 a.m. ET to discuss second quarter results and provide a general business update. To access the con...
THE WOODLANDS, Texas, Aug. 01, 2023 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced financial results for the second quarter 2023 and the six months ended June 30, 2023. Second Quarter 2023 Highlights Net Income of $53.1 million,...
Total net product revenues of $827 million in the second quarter (Q2'23) (+25% Y/Y) Jakafi ® (ruxolitinib) net product revenues of $682 million (+14% Y/Y) in Q2'23; raising the bottom end of full year guidance to a new range of $2.58 - $2.63 billion for FY 2023 Opzelura ...
Highlights (All comparisons are to the prior year period unless otherwise noted) : Net sale s of $480.6 million, up 15% Diluted earnings per share (“EPS”) of $1.04, compared to $1.20 Adjusted diluted EPS* of $1.01, compared to ...
Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals PR Newswire BEIJING , Aug. 1, 2023 /PRNewswire/ -- CASI Ph...
Interim Data Analysis Demonstrates Significant Clinical Improvement and Tolerable Safety Profile in High-Risk Patients Company Provides Clinical Development Plan Update with Pathways to Registration HOUSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a...
Q2 Diluted EPS of $0.70 and Adjusted Diluted EPS of $0.74 Reaffirms 2023 Guidance for U.S. Comparable Restaurant Sales and EPS Bloomin’ Brands, Inc. (Nasdaq: BLMN) today reported results for the second quarter 2023 (“Q2 2023”) compared to the second quarter 20...
RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced today that it ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.27%Change Percent:
Amkor Technology Inc. Company Name:
AMKR Stock Symbol:
NASDAQ Market:
amkor.com Website: